首页 > 最新文献

Genes and immunity最新文献

英文 中文
Apolipoprotein E deficiency leads to the polarization of splenic macrophages towards M1 phenotype by increasing iron content 载脂蛋白 E 缺乏会通过增加铁含量导致脾巨噬细胞向 M1 表型极化。
IF 5 3区 医学 Q1 GENETICS & HEREDITY Pub Date : 2024-08-05 DOI: 10.1038/s41435-024-00290-7
Meng-Qi Shen, Qian Guo, Wei Li, Zhong-Ming Qian
Apolipoprotein E (ApoE) plays a crucial role in iron homeostasis in the body, while macrophages are the principal cells responsible for handling iron in mammals. However, it is unknown whether ApoE can affect the functional subtypes and the iron handling capacity of splenic macrophages (SM). Here, we investigated the effects of ApoE deficiency (ApoE−/−) on the polarization and iron content of SM and its potential mechanisms. ApoE−/− was found to induce a significant increase in the expressions of M1 marker genes CD86, IL-1β, IL-6, IL-12, TNF-α and iNOS and a reduction in M2 marker genes CD206, Arg-1, IL-10 and Ym-1 in SM of mice aged 28 weeks, Meanwhile, ApoE−/− caused a significant increase in iron content and expression of ferritin, transferrin receptor 1 (TfR1), iron regulatory protein 1 (IRP1) and heme oxygenase-1 (HO-1) and a reduction in ferroportin1 (Fpn1) in spleen and/or SM of mice aged 28 weeks. It was concluded that ApoE−/− can increase iron content through increased iron uptake mediated by TfR/ IRPs and decreased iron release mediated by Fpn1, leading to polarization of the SM to M1 phenotype.
载脂蛋白 E(ApoE)在体内铁平衡中起着至关重要的作用,而巨噬细胞是哺乳动物体内负责处理铁的主要细胞。然而,载脂蛋白 E 是否会影响脾脏巨噬细胞(SM)的功能亚型和铁处理能力尚不清楚。在这里,我们研究了载脂蛋白E缺乏(ApoE-/-)对脾巨噬细胞极化和铁含量的影响及其潜在机制。研究发现,载脂蛋白E-/-诱导28周龄小鼠脾脏巨噬细胞中M1标记基因CD86、IL-1β、IL-6、IL-12、TNF-α和iNOS的表达显著增加,M2标记基因CD206、Arg-1、IL-10和Ym-1的表达减少、同时,ApoE-/-导致28周龄小鼠脾脏和/或SM中铁含量和铁蛋白、转铁蛋白受体1(TfR1)、铁调节蛋白1(IRP1)和血红素加氧酶1(HO-1)的表达显著增加,铁蛋白1(Fpn1)减少。结论是载脂蛋白E-/-可通过TfR/IRPs介导的铁摄取增加和Fpn1介导的铁释放减少来增加铁含量,从而导致SM极化为M1表型。
{"title":"Apolipoprotein E deficiency leads to the polarization of splenic macrophages towards M1 phenotype by increasing iron content","authors":"Meng-Qi Shen, Qian Guo, Wei Li, Zhong-Ming Qian","doi":"10.1038/s41435-024-00290-7","DOIUrl":"10.1038/s41435-024-00290-7","url":null,"abstract":"Apolipoprotein E (ApoE) plays a crucial role in iron homeostasis in the body, while macrophages are the principal cells responsible for handling iron in mammals. However, it is unknown whether ApoE can affect the functional subtypes and the iron handling capacity of splenic macrophages (SM). Here, we investigated the effects of ApoE deficiency (ApoE−/−) on the polarization and iron content of SM and its potential mechanisms. ApoE−/− was found to induce a significant increase in the expressions of M1 marker genes CD86, IL-1β, IL-6, IL-12, TNF-α and iNOS and a reduction in M2 marker genes CD206, Arg-1, IL-10 and Ym-1 in SM of mice aged 28 weeks, Meanwhile, ApoE−/− caused a significant increase in iron content and expression of ferritin, transferrin receptor 1 (TfR1), iron regulatory protein 1 (IRP1) and heme oxygenase-1 (HO-1) and a reduction in ferroportin1 (Fpn1) in spleen and/or SM of mice aged 28 weeks. It was concluded that ApoE−/− can increase iron content through increased iron uptake mediated by TfR/ IRPs and decreased iron release mediated by Fpn1, leading to polarization of the SM to M1 phenotype.","PeriodicalId":12691,"journal":{"name":"Genes and immunity","volume":"25 5","pages":"381-388"},"PeriodicalIF":5.0,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141893251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine-learning and scRNA-Seq-based diagnostic and prognostic models illustrating survival and therapy response of lung adenocarcinoma 基于机器学习和 scRNA-Seq 的诊断和预后模型,说明肺腺癌的存活率和治疗反应。
IF 5 3区 医学 Q1 GENETICS & HEREDITY Pub Date : 2024-07-29 DOI: 10.1038/s41435-024-00289-0
Qingyu Cheng, Weidong Zhao, Xiaoyuan Song, Tengchuan Jin
Lung cancer is a major cause accounting for cancer-related mortalities, with lung adenocarcinoma (LUAD) being the most prevalent subtype. Given the high clinical and cellular heterogeneities of LUAD, accurate diagnosis and prognosis are crucial to avoid overdiagnosis and overtreatment. Taking full advantage of scRNA-Seq data to resolve the tumor heterogeneities, we explored the overall landscape of LUAD microenvironment. Utilizing the stage-specific tumor cell markers, we have developed highly accurate diagnostic and prognostic models with elevated sensitivity and specificity. The diagnostic model, developed through random forest algorithms with a thirteen-gene signature, achieved an accuracy of 96.4% and an AUC of 0.993. These metrics were further demonstrated by benchmarking with available models and scoring systems in independent cohorts. Concurrently, the prognostic model, formulated via Cox regression with a six-gene signature, effectively predicted overall survival, with elevated risk scores associated with increased fractions of cancer-associated fibroblasts, and higher likelihood of immune escape and T-cell exclusion. Subsequently, two nomograms were developed to predict survival and drug responses, facilitating their integration into clinical practice. Overall, this study underscores the potential of our models for efficient, rapid, and cost-effective diagnosis and prognosis of LUAD, adaptable to multiple expression profiling platforms and quantification methods.
肺癌是造成癌症相关死亡的主要原因,其中肺腺癌(LUAD)是最常见的亚型。鉴于肺腺癌的临床和细胞异质性较高,准确诊断和预后对于避免过度诊断和过度治疗至关重要。我们充分利用 scRNA-Seq 数据解决肿瘤异质性问题,探索了 LUAD 微环境的整体情况。利用分期特异性肿瘤细胞标记物,我们开发出了具有较高灵敏度和特异性的高精度诊断和预后模型。通过随机森林算法开发的诊断模型具有 13 个基因特征,准确率达到 96.4%,AUC 为 0.993。通过与独立队列中的现有模型和评分系统进行比对,这些指标得到了进一步证实。同时,通过六基因特征的 Cox 回归建立的预后模型能有效预测总生存期,风险评分的升高与癌症相关成纤维细胞的比例增加以及免疫逃逸和 T 细胞排斥的可能性增加有关。随后,研究人员还开发了两个提名图来预测生存率和药物反应,以便将其应用于临床实践。总之,这项研究强调了我们的模型在高效、快速和经济有效地诊断 LUAD 和预后方面的潜力,并能适应多种表达谱平台和量化方法。
{"title":"Machine-learning and scRNA-Seq-based diagnostic and prognostic models illustrating survival and therapy response of lung adenocarcinoma","authors":"Qingyu Cheng, Weidong Zhao, Xiaoyuan Song, Tengchuan Jin","doi":"10.1038/s41435-024-00289-0","DOIUrl":"10.1038/s41435-024-00289-0","url":null,"abstract":"Lung cancer is a major cause accounting for cancer-related mortalities, with lung adenocarcinoma (LUAD) being the most prevalent subtype. Given the high clinical and cellular heterogeneities of LUAD, accurate diagnosis and prognosis are crucial to avoid overdiagnosis and overtreatment. Taking full advantage of scRNA-Seq data to resolve the tumor heterogeneities, we explored the overall landscape of LUAD microenvironment. Utilizing the stage-specific tumor cell markers, we have developed highly accurate diagnostic and prognostic models with elevated sensitivity and specificity. The diagnostic model, developed through random forest algorithms with a thirteen-gene signature, achieved an accuracy of 96.4% and an AUC of 0.993. These metrics were further demonstrated by benchmarking with available models and scoring systems in independent cohorts. Concurrently, the prognostic model, formulated via Cox regression with a six-gene signature, effectively predicted overall survival, with elevated risk scores associated with increased fractions of cancer-associated fibroblasts, and higher likelihood of immune escape and T-cell exclusion. Subsequently, two nomograms were developed to predict survival and drug responses, facilitating their integration into clinical practice. Overall, this study underscores the potential of our models for efficient, rapid, and cost-effective diagnosis and prognosis of LUAD, adaptable to multiple expression profiling platforms and quantification methods.","PeriodicalId":12691,"journal":{"name":"Genes and immunity","volume":"25 5","pages":"356-366"},"PeriodicalIF":5.0,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141792302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of the ferroptosis‐related gene signature and the associated regulation axis in lung cancer and rheumatoid arthritis 确定肺癌和类风湿性关节炎中的铁蛋白沉积相关基因特征及相关调控轴。
IF 5 3区 医学 Q1 GENETICS & HEREDITY Pub Date : 2024-07-29 DOI: 10.1038/s41435-024-00287-2
Bo Cai, Yibin Huang, Dandan Liu, Yizheng You, Nuoshi Chen, Ligang Jie, Hongyan Du
Patients with Rheumatoid arthritis (RA) have an elevated risk of lung cancer compared to the healthy population. However, there are few studies on the relationship between RA and lung adenocarcinoma (LUAD), especially the mechanisms at the genetic level. In this study, we investigated the link between RA and LUAD regarding Ferroptosis-Related Genes. The RNA-seq data of RA (GSE77298 and GSE 82107) and LUAD(GSE75037) in the Gene Expression Omnibus (GEO) database were obtained. 259 ferroptosis-related genes were obtained from the website ( http://www.zhounan.org/ferrdb/ ).The differential genes obtained from the RA and LUAD datasets were intersected with ferroptosis-related genes to obtain the ferroptosis-related differentially expressed genes (FRDEGs). Next, the mRNA-miRNA network was constructed, then Gene Set Enrichment Analysis (GSEA) for target genes were performed. The CIBERSORT algorithm was used to analyze the immune infiltration. Finally, the results were validated using external datasets (GSE89408 and GSE48780) and The Cancer Genome Atlas (TCGA) dataset. We obtained FRDEGs common to LUAD and RA: FANCD2, HELLS, RRM2, G6PD, VLDLR. These five genes play important roles in the progression of RA and LUAD. They also hold great diagnostic value for both diseases. Also, we found that LUAD and RA share common signaling pathways and similar immune mechanisms.
与健康人群相比,类风湿性关节炎(RA)患者罹患肺癌的风险较高。然而,有关 RA 与肺腺癌(LUAD)之间关系的研究很少,尤其是基因层面的机制。在这项研究中,我们调查了RA与肺腺癌之间有关铁突变相关基因的联系。我们从基因表达总库(GEO)中获得了RA(GSE77298和GSE82107)和LUAD(GSE75037)的RNA-seq数据。从网站( http://www.zhounan.org/ferrdb/ )上获得了 259 个铁变态反应相关基因。将从 RA 和 LUAD 数据集中获得的差异基因与铁变态反应相关基因进行交叉,得到了铁变态反应相关差异表达基因(FRDEGs)。接着,构建 mRNA-miRNA 网络,然后对目标基因进行基因组富集分析(Gene Set Enrichment Analysis,GSEA)。CIBERSORT 算法用于分析免疫浸润。最后,利用外部数据集(GSE89408 和 GSE48780)和癌症基因组图谱(TCGA)数据集对结果进行了验证。我们获得了 LUAD 和 RA 的共同 FRDEGs:FANCD2、HELLS、RRM2、G6PD、VLDLR。这五个基因在 RA 和 LUAD 的进展过程中起着重要作用。它们对这两种疾病也具有重要的诊断价值。此外,我们还发现 LUAD 和 RA 有共同的信号通路和相似的免疫机制。
{"title":"Identification of the ferroptosis‐related gene signature and the associated regulation axis in lung cancer and rheumatoid arthritis","authors":"Bo Cai, Yibin Huang, Dandan Liu, Yizheng You, Nuoshi Chen, Ligang Jie, Hongyan Du","doi":"10.1038/s41435-024-00287-2","DOIUrl":"10.1038/s41435-024-00287-2","url":null,"abstract":"Patients with Rheumatoid arthritis (RA) have an elevated risk of lung cancer compared to the healthy population. However, there are few studies on the relationship between RA and lung adenocarcinoma (LUAD), especially the mechanisms at the genetic level. In this study, we investigated the link between RA and LUAD regarding Ferroptosis-Related Genes. The RNA-seq data of RA (GSE77298 and GSE 82107) and LUAD(GSE75037) in the Gene Expression Omnibus (GEO) database were obtained. 259 ferroptosis-related genes were obtained from the website ( http://www.zhounan.org/ferrdb/ ).The differential genes obtained from the RA and LUAD datasets were intersected with ferroptosis-related genes to obtain the ferroptosis-related differentially expressed genes (FRDEGs). Next, the mRNA-miRNA network was constructed, then Gene Set Enrichment Analysis (GSEA) for target genes were performed. The CIBERSORT algorithm was used to analyze the immune infiltration. Finally, the results were validated using external datasets (GSE89408 and GSE48780) and The Cancer Genome Atlas (TCGA) dataset. We obtained FRDEGs common to LUAD and RA: FANCD2, HELLS, RRM2, G6PD, VLDLR. These five genes play important roles in the progression of RA and LUAD. They also hold great diagnostic value for both diseases. Also, we found that LUAD and RA share common signaling pathways and similar immune mechanisms.","PeriodicalId":12691,"journal":{"name":"Genes and immunity","volume":"25 5","pages":"367-380"},"PeriodicalIF":5.0,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141855280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The shared role of neutrophils in ankylosing spondylitis and ulcerative colitis 中性粒细胞在强直性脊柱炎和溃疡性结肠炎中的共同作用。
IF 5 3区 医学 Q1 GENETICS & HEREDITY Pub Date : 2024-07-25 DOI: 10.1038/s41435-024-00286-3
Tianyou Chen, Weiming Tan, Xinli Zhan, Chenxing Zhou, Jichong Zhu, Shaofeng Wu, Boli Qin, Rongqing He, Xiaopeng Qin, Wendi Wei, Chengqian Huang, Bin Zhang, Sitan Feng, Chong Liu
This study aimed to analyze single-cell sequencing data to investigate immune cell interactions in ankylosing spondylitis (AS) and ulcerative colitis (UC). Vertebral bone marrow blood was collected from three AS patients for 10X single-cell sequencing. Analysis of single-cell data revealed distinct cell types in AS and UC patients. Cells significantly co-expressing immune cells (P < 0.05) were subjected to communication analysis. Overlapping genes of these co-expressing immune cells were subjected to GO and KEGG analyses. Key genes were identified using STRING and Cytoscape to assess their correlation with immune cell expression. The results showed the significance of neutrophils in both diseases (P < 0.01), with notable interactions identified through communication analysis. XBP1 emerged as a Hub gene for both diseases, with AUC values of 0.760 for AS and 0.933 for UC. Immunohistochemistry verified that the expression of XBP1 was significantly lower in the AS group and significantly greater in the UC group than in the control group (P < 0.01). This finding highlights the critical role of neutrophils in both AS and UC, suggesting the presence of shared immune response elements. The identification of XBP1 as a potential therapeutic target offers promising intervention avenues for both diseases.
本研究旨在分析单细胞测序数据,研究强直性脊柱炎(AS)和溃疡性结肠炎(UC)中免疫细胞的相互作用。研究人员采集了三名强直性脊柱炎患者的椎骨骨髓血,进行了10倍单细胞测序。单细胞数据分析显示,强直性脊柱炎和溃疡性结肠炎患者的细胞类型截然不同。明显共同表达免疫细胞的细胞(P
{"title":"The shared role of neutrophils in ankylosing spondylitis and ulcerative colitis","authors":"Tianyou Chen,&nbsp;Weiming Tan,&nbsp;Xinli Zhan,&nbsp;Chenxing Zhou,&nbsp;Jichong Zhu,&nbsp;Shaofeng Wu,&nbsp;Boli Qin,&nbsp;Rongqing He,&nbsp;Xiaopeng Qin,&nbsp;Wendi Wei,&nbsp;Chengqian Huang,&nbsp;Bin Zhang,&nbsp;Sitan Feng,&nbsp;Chong Liu","doi":"10.1038/s41435-024-00286-3","DOIUrl":"10.1038/s41435-024-00286-3","url":null,"abstract":"This study aimed to analyze single-cell sequencing data to investigate immune cell interactions in ankylosing spondylitis (AS) and ulcerative colitis (UC). Vertebral bone marrow blood was collected from three AS patients for 10X single-cell sequencing. Analysis of single-cell data revealed distinct cell types in AS and UC patients. Cells significantly co-expressing immune cells (P &lt; 0.05) were subjected to communication analysis. Overlapping genes of these co-expressing immune cells were subjected to GO and KEGG analyses. Key genes were identified using STRING and Cytoscape to assess their correlation with immune cell expression. The results showed the significance of neutrophils in both diseases (P &lt; 0.01), with notable interactions identified through communication analysis. XBP1 emerged as a Hub gene for both diseases, with AUC values of 0.760 for AS and 0.933 for UC. Immunohistochemistry verified that the expression of XBP1 was significantly lower in the AS group and significantly greater in the UC group than in the control group (P &lt; 0.01). This finding highlights the critical role of neutrophils in both AS and UC, suggesting the presence of shared immune response elements. The identification of XBP1 as a potential therapeutic target offers promising intervention avenues for both diseases.","PeriodicalId":12691,"journal":{"name":"Genes and immunity","volume":"25 4","pages":"324-335"},"PeriodicalIF":5.0,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141765878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validating genetic variants in innate immunity linked to infectious events in acute myeloid leukemia post-induction chemotherapy 验证与急性髓性白血病诱导化疗后感染事件有关的先天性免疫基因变异。
IF 5 3区 医学 Q1 GENETICS & HEREDITY Pub Date : 2024-07-09 DOI: 10.1038/s41435-024-00285-4
Ulf Schnetzke, Mike Fischer, Christoph Röllig, André Scherag, Heidi Altmann, Friedrich Stölzel, Nael Alakel, Martin Bornhäuser, Andreas Hochhaus, Sebastian Scholl
Infectious events, such as sepsis and invasive fungal disease (IFD), pose significant risks in patients with acute myeloid leukemia (AML). Previous studies, including our own, have suggested a potential role of single nucleotide polymorphisms (SNPs) within the innate immune system in influencing individual infection susceptibility. However, many of these associations lack validation in independent cohorts. This study sought to validate the impact of 11 candidate SNPs across 6 genes (TLR2, TLR4, Dectin-1, DC-SIGN, PTX3, L-Ficolin) in an independent cohort of patients. Two cohorts with newly diagnosed AML patients receiving intensive induction chemotherapy were analyzed: a stratification cohort comprising 186 patients and a validation cohort consisting of 138 patients. Multiple SNPs in each cohort were found to be associated to infectious complications, notably the DC-SIGN SNP rs4804800 demonstrated a significant association with sepsis in both cohorts. SNPs within the PTX3 and Dectin-1 genes were linked to IFD development in one cohort each. This study represents the first validation study of candidate genes associated with infectious events in AML patients after intensive induction chemotherapy. Identifying genetic predispositions to infections could significantly impact the management of antimicrobial prophylaxis and treatment in AML patients.
败血症和侵袭性真菌病(IFD)等感染事件对急性髓性白血病(AML)患者构成重大风险。包括我们自己在内的以往研究表明,先天性免疫系统中的单核苷酸多态性(SNPs)在影响个体感染易感性方面具有潜在作用。然而,其中许多关联缺乏独立队列的验证。本研究试图在一个独立的患者队列中验证 6 个基因(TLR2、TLR4、Dectin-1、DC-SIGN、PTX3、L-Ficolin)中 11 个候选 SNPs 的影响。对接受强化诱导化疗的新诊断急性髓细胞白血病患者的两个队列进行了分析:一个是由 186 名患者组成的分层队列,另一个是由 138 名患者组成的验证队列。发现每个队列中的多个 SNP 与感染并发症有关,尤其是 DC-SIGN SNP rs4804800 与两个队列中的败血症均有显著关联。在一个队列中,PTX3 和 Dectin-1 基因中的 SNP 与 IFD 的发生有关。这项研究是首次验证与强化诱导化疗后急性髓细胞白血病患者感染事件相关的候选基因。确定感染的遗传倾向可能会对 AML 患者的抗菌预防和治疗管理产生重大影响。
{"title":"Validating genetic variants in innate immunity linked to infectious events in acute myeloid leukemia post-induction chemotherapy","authors":"Ulf Schnetzke,&nbsp;Mike Fischer,&nbsp;Christoph Röllig,&nbsp;André Scherag,&nbsp;Heidi Altmann,&nbsp;Friedrich Stölzel,&nbsp;Nael Alakel,&nbsp;Martin Bornhäuser,&nbsp;Andreas Hochhaus,&nbsp;Sebastian Scholl","doi":"10.1038/s41435-024-00285-4","DOIUrl":"10.1038/s41435-024-00285-4","url":null,"abstract":"Infectious events, such as sepsis and invasive fungal disease (IFD), pose significant risks in patients with acute myeloid leukemia (AML). Previous studies, including our own, have suggested a potential role of single nucleotide polymorphisms (SNPs) within the innate immune system in influencing individual infection susceptibility. However, many of these associations lack validation in independent cohorts. This study sought to validate the impact of 11 candidate SNPs across 6 genes (TLR2, TLR4, Dectin-1, DC-SIGN, PTX3, L-Ficolin) in an independent cohort of patients. Two cohorts with newly diagnosed AML patients receiving intensive induction chemotherapy were analyzed: a stratification cohort comprising 186 patients and a validation cohort consisting of 138 patients. Multiple SNPs in each cohort were found to be associated to infectious complications, notably the DC-SIGN SNP rs4804800 demonstrated a significant association with sepsis in both cohorts. SNPs within the PTX3 and Dectin-1 genes were linked to IFD development in one cohort each. This study represents the first validation study of candidate genes associated with infectious events in AML patients after intensive induction chemotherapy. Identifying genetic predispositions to infections could significantly impact the management of antimicrobial prophylaxis and treatment in AML patients.","PeriodicalId":12691,"journal":{"name":"Genes and immunity","volume":"25 4","pages":"317-323"},"PeriodicalIF":5.0,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.com/articles/s41435-024-00285-4.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141563233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cells SARS-CoV-2 病毒在肺泡巨噬细胞中的持续存在受 IFN-γ 和 NK 细胞的控制。
IF 5 3区 医学 Q1 GENETICS & HEREDITY Pub Date : 2024-06-26 DOI: 10.1038/s41435-024-00284-5
Emma Beaumont, Michaela Müller-Trutwin, Nicolas Huot
{"title":"SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cells","authors":"Emma Beaumont,&nbsp;Michaela Müller-Trutwin,&nbsp;Nicolas Huot","doi":"10.1038/s41435-024-00284-5","DOIUrl":"10.1038/s41435-024-00284-5","url":null,"abstract":"","PeriodicalId":12691,"journal":{"name":"Genes and immunity","volume":"25 5","pages":"443-445"},"PeriodicalIF":5.0,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141456317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The ability of microRNAs to regulate the immune response in ischemia/reperfusion inflammatory pathways microRNA 在缺血/再灌注炎症途径中调节免疫反应的能力。
IF 5 3区 医学 Q1 GENETICS & HEREDITY Pub Date : 2024-06-22 DOI: 10.1038/s41435-024-00283-6
Peter Artimovič, Ivana Špaková, Ema Macejková, Timea Pribulová, Miroslava Rabajdová, Mária Mareková, Martina Zavacká
MicroRNAs play a crucial role in regulating the immune responses induced by ischemia/reperfusion injury. Through their ability to modulate gene expression, microRNAs adjust immune responses by targeting specific genes and signaling pathways. This review focuses on the impact of microRNAs on the inflammatory pathways triggered during ischemia/reperfusion injury and highlights their ability to modulate inflammation, playing a critical role in the pathophysiology of ischemia/reperfusion injury. Dysregulated expression of microRNAs contributes to the pathogenesis of ischemia/reperfusion injury, therefore targeting specific microRNAs offers an opportunity to restore immune homeostasis and improve patient outcomes. Understanding the complex network of immunoregulatory microRNAs could provide novel therapeutic interventions aimed at attenuating excessive inflammation and preserving tissue integrity.
微RNA在调节缺血/再灌注损伤诱导的免疫反应中发挥着至关重要的作用。通过调节基因表达的能力,microRNA 通过靶向特定基因和信号通路来调整免疫反应。本综述重点探讨 microRNA 对缺血/再灌注损伤过程中触发的炎症通路的影响,并强调其调节炎症的能力在缺血/再灌注损伤的病理生理学中发挥着关键作用。微小RNA表达失调是缺血再灌注损伤的发病机制之一,因此靶向特定的微小RNA为恢复免疫平衡和改善患者预后提供了机会。了解免疫调节microRNAs的复杂网络可以提供新的治疗干预措施,以减轻过度炎症反应并保护组织完整性。
{"title":"The ability of microRNAs to regulate the immune response in ischemia/reperfusion inflammatory pathways","authors":"Peter Artimovič,&nbsp;Ivana Špaková,&nbsp;Ema Macejková,&nbsp;Timea Pribulová,&nbsp;Miroslava Rabajdová,&nbsp;Mária Mareková,&nbsp;Martina Zavacká","doi":"10.1038/s41435-024-00283-6","DOIUrl":"10.1038/s41435-024-00283-6","url":null,"abstract":"MicroRNAs play a crucial role in regulating the immune responses induced by ischemia/reperfusion injury. Through their ability to modulate gene expression, microRNAs adjust immune responses by targeting specific genes and signaling pathways. This review focuses on the impact of microRNAs on the inflammatory pathways triggered during ischemia/reperfusion injury and highlights their ability to modulate inflammation, playing a critical role in the pathophysiology of ischemia/reperfusion injury. Dysregulated expression of microRNAs contributes to the pathogenesis of ischemia/reperfusion injury, therefore targeting specific microRNAs offers an opportunity to restore immune homeostasis and improve patient outcomes. Understanding the complex network of immunoregulatory microRNAs could provide novel therapeutic interventions aimed at attenuating excessive inflammation and preserving tissue integrity.","PeriodicalId":12691,"journal":{"name":"Genes and immunity","volume":"25 4","pages":"277-296"},"PeriodicalIF":5.0,"publicationDate":"2024-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.com/articles/s41435-024-00283-6.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141440409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Getting under the skin: resident memory CD8+ T cells have a second residence in the draining lymph node 更正:深入皮下:常驻记忆 CD8+ T 细胞在引流淋巴结有第二居所。
IF 5 3区 医学 Q1 GENETICS & HEREDITY Pub Date : 2024-06-19 DOI: 10.1038/s41435-024-00282-7
Teresa Neuwirth, Azuah L. Gonzalez, Emilie Fisher-Gupta, Georg Stary
{"title":"Correction: Getting under the skin: resident memory CD8+ T cells have a second residence in the draining lymph node","authors":"Teresa Neuwirth,&nbsp;Azuah L. Gonzalez,&nbsp;Emilie Fisher-Gupta,&nbsp;Georg Stary","doi":"10.1038/s41435-024-00282-7","DOIUrl":"10.1038/s41435-024-00282-7","url":null,"abstract":"","PeriodicalId":12691,"journal":{"name":"Genes and immunity","volume":"25 4","pages":"351-351"},"PeriodicalIF":5.0,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.com/articles/s41435-024-00282-7.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141426694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PARP inhibitor and immune checkpoint inhibitor have synergism efficacy in gallbladder cancer PARP抑制剂和免疫检查点抑制剂对胆囊癌有协同疗效
IF 5 3区 医学 Q1 GENETICS & HEREDITY Pub Date : 2024-06-12 DOI: 10.1038/s41435-024-00280-9
Yu Chen, Xudong Fan, Ruohuang Lu, Shan Zeng, Pingping Gan
Gallbladder cancer (GBC) is an aggressive cancer with poor prognosis. PARP inhibitors (PARPi) target PARP enzymes and have shown efficacy in patients with breast cancer gene (BRCA) mutations. Immunotherapy, especially immune checkpoint inhibitors (ICIs), has transformed cancer treatment. However, the combined impact of PARPi and ICIs in GBC remains unclear. We present a groundbreaking case of a GBC patient with BRCA2 mutations who received combination therapy with PARPi and ICIs after failing multiple lines of treatment. Next-generation sequencing (NGS-Seq) identified BRCA gene mutations. To further investigate potential mechanisms, we developed a PARP1-BRCA1-BRCA2 pathway-related risk score (PBscore) system to evaluate the impact of PARPi on the tumor immune microenvironment via RNA-Seq data. Gene expression and functional analysis identified potential mechanisms associated with the PBscore. Experimental validation assessed the impact of the combination therapy on the tumor microenvironment using multiplexed immunofluorescence imaging and immunohistochemistry in patients with BRCA gene wild type or mutations. RNA-Seq analysis revealed correlations between PBscore, immune checkpoint levels, tumor-infiltrating immune cells (TIICs), and the cancer-immunity cycle. Multiplexed immunofluorescence imaging validated that low PBscore patients might have an active tumor microenvironment. Furthermore, upon drug resistance, we observed an upregulation of negative immune checkpoints such as CEACAM1, indicating that the tumor immune microenvironment becomes suppressed after resistance. Our study revealed that PBscore could serve as a biomarker to predict immunotherapy efficacy, offering a promising alternative for BRCA2-mutated GBC patients.
胆囊癌(GBC)是一种侵袭性癌症,预后较差。PARP 抑制剂(PARPi)以 PARP 酶为靶点,对乳腺癌基因(BRCA)突变的患者有疗效。免疫疗法,尤其是免疫检查点抑制剂(ICIs),已经改变了癌症治疗。然而,PARPi 和 ICIs 对 GBC 的综合影响仍不清楚。我们介绍了一例具有突破性意义的病例:一名 BRCA2 突变的 GBC 患者在多线治疗失败后接受了 PARPi 和 ICIs 的联合治疗。下一代测序(NGS-Seq)确定了 BRCA 基因突变。为了进一步研究潜在机制,我们开发了 PARP1-BRCA1-BRCA2 通路相关风险评分(PBscore)系统,通过 RNA-Seq 数据评估 PARPi 对肿瘤免疫微环境的影响。基因表达和功能分析确定了与 PBscore 相关的潜在机制。实验验证在 BRCA 基因野生型或突变患者中使用多重免疫荧光成像和免疫组化技术评估了联合疗法对肿瘤微环境的影响。RNA-Seq分析显示了PBscore、免疫检查点水平、肿瘤浸润免疫细胞(TIIC)和癌症免疫周期之间的相关性。多重免疫荧光成像验证了低PBscore患者可能具有活跃的肿瘤微环境。此外,在耐药后,我们观察到负性免疫检查点(如 CEACAM1)上调,这表明耐药后肿瘤免疫微环境会受到抑制。我们的研究表明,PBscore 可作为预测免疫疗法疗效的生物标记物,为 BRCA2 突变的 GBC 患者提供了一种有希望的选择。
{"title":"PARP inhibitor and immune checkpoint inhibitor have synergism efficacy in gallbladder cancer","authors":"Yu Chen,&nbsp;Xudong Fan,&nbsp;Ruohuang Lu,&nbsp;Shan Zeng,&nbsp;Pingping Gan","doi":"10.1038/s41435-024-00280-9","DOIUrl":"10.1038/s41435-024-00280-9","url":null,"abstract":"Gallbladder cancer (GBC) is an aggressive cancer with poor prognosis. PARP inhibitors (PARPi) target PARP enzymes and have shown efficacy in patients with breast cancer gene (BRCA) mutations. Immunotherapy, especially immune checkpoint inhibitors (ICIs), has transformed cancer treatment. However, the combined impact of PARPi and ICIs in GBC remains unclear. We present a groundbreaking case of a GBC patient with BRCA2 mutations who received combination therapy with PARPi and ICIs after failing multiple lines of treatment. Next-generation sequencing (NGS-Seq) identified BRCA gene mutations. To further investigate potential mechanisms, we developed a PARP1-BRCA1-BRCA2 pathway-related risk score (PBscore) system to evaluate the impact of PARPi on the tumor immune microenvironment via RNA-Seq data. Gene expression and functional analysis identified potential mechanisms associated with the PBscore. Experimental validation assessed the impact of the combination therapy on the tumor microenvironment using multiplexed immunofluorescence imaging and immunohistochemistry in patients with BRCA gene wild type or mutations. RNA-Seq analysis revealed correlations between PBscore, immune checkpoint levels, tumor-infiltrating immune cells (TIICs), and the cancer-immunity cycle. Multiplexed immunofluorescence imaging validated that low PBscore patients might have an active tumor microenvironment. Furthermore, upon drug resistance, we observed an upregulation of negative immune checkpoints such as CEACAM1, indicating that the tumor immune microenvironment becomes suppressed after resistance. Our study revealed that PBscore could serve as a biomarker to predict immunotherapy efficacy, offering a promising alternative for BRCA2-mutated GBC patients.","PeriodicalId":12691,"journal":{"name":"Genes and immunity","volume":"25 4","pages":"307-316"},"PeriodicalIF":5.0,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141310468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sphingomyelin-derived epacadostat nanovesicle enhances IDO1 inhibition for improved melanoma combination immunotherapy 鞘磷脂衍生的依帕卡托司他纳米囊泡可增强对 IDO1 的抑制,从而改善黑色素瘤联合免疫疗法。
IF 5 3区 医学 Q1 GENETICS & HEREDITY Pub Date : 2024-06-11 DOI: 10.1038/s41435-024-00281-8
Zhiren Wang, Wenpan Li, Jianqin Lu
{"title":"Sphingomyelin-derived epacadostat nanovesicle enhances IDO1 inhibition for improved melanoma combination immunotherapy","authors":"Zhiren Wang,&nbsp;Wenpan Li,&nbsp;Jianqin Lu","doi":"10.1038/s41435-024-00281-8","DOIUrl":"10.1038/s41435-024-00281-8","url":null,"abstract":"","PeriodicalId":12691,"journal":{"name":"Genes and immunity","volume":"25 5","pages":"440-442"},"PeriodicalIF":5.0,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141300536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Genes and immunity
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1